Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital

被引:9
|
作者
Zhang, Di [1 ]
Cui, Kai [2 ]
Wang, Taotao [1 ]
Shan, Yuanyuan [1 ]
Dong, Haiyan [1 ]
Feng, Weiyi [1 ]
Ma, Chen [1 ,3 ]
Dong, Yalin [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Pharm, Yanta West Rd 277, Xian 710061, Shaanxi, Peoples R China
[2] Xian Univ Posts & Telecommun, Dept Management Econ, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Clin Lab, Xian, Shaanxi, Peoples R China
来源
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2018年 / 12卷 / 08期
关键词
Pseudomonas aeruginosa; carbapenem resistantance; risk factors; mortality; ANTIMICROBIAL RESISTANCE; BACTEREMIA; ENTEROBACTERIACEAE; SELECTION;
D O I
10.3855/jidc.10150
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is rapidly emerging as a life-threatening nosocomial infection. In this study, we aimed to identify risk factors, especially antibiotic use and co-carriage with other bacteria for CRPA infection or colonization. Methodology: A retrospective study was conducted in the First Affiliated Hospital of Xi'an Jiaotong University, which involved a cohort of patients with Pseudomonas aeruginosa infection or colonization from January 2014 to June 2016. Univariate analysis and multivariate analysis were performed to estimate the risk factors of CRPA occurrence. Results: Eight hundred and eighty-eight patients were included in the study. More than 50% of the risk factors were associated with CRPA infection or colonization according to univariate analysis (P < 0.05), such as invasive procedures, co-carriage with Gram-negative pathogens, and prior treatment with some antibiotics. However, only prior exposure to carbapenems (OR: 8.005; CI: 4.507-14.217, P < 0.001), the days of carbapenems treatment (OR: 1.190; CI: 1.073-1.272; P < 0.001), and co-carriage with Escherichia coli (OR: 1.824; CI: 1.005-3.310, P = 0.048) were considered independent risk factors by multivariate analysis. A higher mortality was found among patients with CRPA infection or colonization (P < 0.05). Conclusions: Risk factors for CRPA infection or colonization were prior exposure to carbapenems, the days of carbapenems treatment, and co-carriage with Escherichia coli. The prevalence of CRPA could be influenced by Gram-negative pathogens, especially in Escherichia coli, and it need more researches. Moreover, restrictions in the clinical use of carbapenems should be taken into account.
引用
收藏
页码:642 / 648
页数:7
相关论文
共 50 条
  • [21] Challenges of Carbapenem-resistant Pseudomonas aeruginosa in Infection Control and Antibiotic Management
    Kim, Young Jin
    Huh, Hee Jae
    Sung, Heungsup
    ANNALS OF LABORATORY MEDICINE, 2024, 44 (01) : 1 - 2
  • [22] Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis
    Sophonsri, Anthony
    Kelsom, Corey
    Lou, Mimi
    Nieberg, Paul
    Wong-Beringer, Annie
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [23] Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis
    Britt, Nicholas S.
    Ritchie, David J.
    Kollef, Marin H.
    Burnham, Carey-Ann D.
    Durkin, Michael J.
    Hampton, Nicholas B.
    Micek, Scott T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [24] Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
    Wang, Zhe
    Qin, Ran-Ran
    Huang, Lei
    Sun, Li-Ying
    CHINESE MEDICAL JOURNAL, 2018, 131 (01) : 56 - 62
  • [25] Pattern of cephalosporin and carbapenem-resistant Pseudomonas aeruginosa: a retrospective analysis
    Albahrani, Salma
    Alqazih, Thikrayat Qazih
    Aseeri, Ali Ahmad
    Al Argan, Reem
    Alkhafaji, Dania
    Alrqyai, Nora Abdullah
    Alanazi, Sami Mohamed
    Aldakheel, Dima Saleh
    Ghazwani, Qassim Hassan
    Jalalah, Salah Saeed
    Alshuaibi, Anwar Khalid
    Hazzazi, Hanadi Ali
    Al-Tawfiq, Jaffar A.
    IJID REGIONS, 2024, 10 : 31 - 34
  • [26] Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
    Vivo, Amanda
    Fitzpatrick, Margaret A.
    Suda, Katie J.
    Jones, Makoto M.
    Perencevich, Eli N.
    Rubin, Michael A.
    Ramanathan, Swetha
    Wilson, Geneva M.
    Evans, Martin E.
    Evans, Charlesnika T.
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [27] Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit
    Kohlenberg, A.
    Weitzel-Kage, D.
    van der Linden, P.
    Sohr, D.
    Voegeler, S.
    Kola, A.
    Halle, E.
    Rueden, H.
    Weist, K.
    JOURNAL OF HOSPITAL INFECTION, 2010, 74 (04) : 350 - 357
  • [28] Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study
    Henig, O.
    Weber, G.
    Hoshen, M. B.
    Paul, M.
    German, L.
    Neuberger, A.
    Gluzman, I.
    Berlin, A.
    Shapira, C.
    Balicer, R. D.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (10) : 2063 - 2068
  • [29] Antibiotic susceptibility pattern, risk factors, and prediction of carbapenem-resistant Pseudomonas aeruginosa in patients with nosocomial pneumonia
    Liu, Yao
    Xu, Yifei
    Wang, Shu
    Zeng, Zhangrui
    Li, Zhaoyinqian
    Din, Yinhuan
    Liu, Jinbo
    HELIYON, 2023, 9 (05)
  • [30] Colonization pressure as a risk factor for colonization by multiresistant Acinetobacter spp and carbapenem-resistant Pseudomonas aeruginosa in an intensive care unit
    DalBen, Mirian Freitas
    Basso, Mariusa
    Garcia, Cilmara Polido
    Costa, Silvia Figueiredo
    Toscano, Cristiana Maria
    Jarvis, William Robert
    Lobo, Renata Desordi
    Oliveira, Maura Salaroli
    Levin, Anna Sara
    CLINICS, 2013, 68 (08) : 1128 - 1133